Dr. Peter R. Carroll, MD

Dr. Carroll practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Carroll's NPI, 1366461667, was assigned on July 18, 2006. Dr. Carroll graduated from Georgetown University School Of Medicine in 1979. Dr. Carroll's California license number on file is A35750.

Dr. Carroll's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Carroll's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Carroll is also affiliated with MarinHealth Medical Center. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Carroll to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Carroll practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Carroll's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Carroll is board certified in urology by the American Board of Urology. Dmand AI has Dr. Carroll's licenses on file in 2 states: California and New York.

Dmand AI lists enlarged prostate, kidney cysts, prostate cancer, prostate surgery, transurethral procedures, urinary endoscopy and UTI among the conditions Dr. Carroll treats.

CMS data shows 920 Medicare services from Dr. Carroll across 9 procedure codes in 2024, for 433 Medicare patients. Medicare paid $106,569 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 433 Medicare patients who saw Dr. Carroll in 2024. The largest group is 65 to 74, with 238 patients. 75% of them have cancer, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Carroll's median patient age at 72, with 2% women.

In 2024, Dr. Carroll wrote 93 Medicare Part D claims for 33 patients. 99% of them were for generic drugs. CMS names the drug for 67 of them, across 2 drugs with 11 or more claims each, at $807 in total drug cost. In 2023, CMS named 43 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Carroll for performance year 2024, reported as part of a group. Dr. Carroll accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Carroll as offering telehealth. CMS counts 25 procedures of prostate resection by Dr. Carroll, more than 87% of the clinicians it reports for that procedure.

Dmand AI links 660 papers to Dr. Carroll, published from 2004 to 2025. 2020 was the busiest year, with 27. The most frequent topics are Prostatic Neoplasms, Prostatectomy and Prostate-Specific Antigen. Dr. Carroll has published most often in J Urol. Dr. Carroll's most frequent co-authors are Matthew R. Cooperberg, MD, Hao G. Nguyen, MD and Maxwell V. Meng, MD.

Dmand AI links Dr. Carroll to 16 clinical trials, 5 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Prostatic Neoplasms, Prostatic Diseases and Anemia, Aplastic. University of California, San Francisco sponsors the most, 6.

CMS Open Payments shows 26 general payments to Dr. Carroll from 9 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 42% of the total. Genentech, Inc. paid the most, $12,199.

Dmand AI lists 6 awards for Dr. Carroll, most recently America's Top Doctors in 2014.

Dr. Carroll graduated from Georgetown University School Of Medicine in 1979. Dr. Carroll is a member of ACS.

Dr. Carroll is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.